{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:02:08Z","timestamp":1791147728873,"version":"4.1.0"},"reference-count":69,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,11,9]],"date-time":"2006-11-09T00:00:00Z","timestamp":1163030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold><jats:bold>Background:\u2002<\/jats:bold>Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both \u2018\u2018direct\u2019\u2019 and \u2018\u2018indirect\u2019\u2019 effects including allograft rejection, decreased graft and patient survival, and predisposition to opportunistic infections and malignancies. Options for CMV prevention include pre\u2010emptive therapy, whereby anti\u2010CMV agents are administered based on sensitive viral assays, or universal prophylaxis of all at\u2010risk patients. Each approach has advantages and disadvantages in terms of efficacy, costs, and side effects. Standards of care for prophylaxis have not been established.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>A committee of international experts was convened to review the available data regarding CMV prophylaxis and to compare preventative strategies for CMV after transplantation from seropositive donors or in seropositive recipients.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Pre\u2010emptive therapy requires frequent monitoring with subsequent treatment of disease and associated costs, while universal prophylaxis results in greater exposure to potential toxicities and costs of drugs. The advantages of prophylaxis include suppressing asymptomatic viremia and prevention of both direct and indirect effects of CMV infection. Meta analyses reveal decreased in mortality for patients receiving CMV prophylaxis. Costs associated with prophylaxis are less than for routine monitoring and pre\u2010emptive therapy. The optimal duration of antiviral prophylaxis remains undefined. Extended prophylaxis may improve clinical outcomes in the highest\u2010risk patient populations including donor\u2010seropositive\/recipient\u2010seronegative renal transplants and in CMV\u2010infected lung and heart transplantation.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>Prophylaxis is beneficial in preventing direct and indirect effects of CMV infection in transplant recipients, affecting both allograft and patient survival. More studies are necessary to define optimal prophylaxis regimens.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2006.00618.x","type":"journal-article","created":{"date-parts":[[2006,11,9]],"date-time":"2006-11-09T17:12:49Z","timestamp":1163092369000},"page":"149-158","source":"Crossref","is-referenced-by-count":242,"title":["Cytomegalovirus in transplantation \u2013 challenging the<i>status quo<\/i>"],"prefix":"10.1111","volume":"21","author":[{"given":"Jay A","family":"Fishman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Sgarabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Torre\u2010Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E","family":"Uknis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,10]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806113382407"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.54.2.84"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66553-1"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1079"},{"key":"e_1_2_10_6_2","volume-title":"Infection in Renal Transplant Recipients in Chronic Kidney Disease, Dialysis and Transplantation","author":"Fishman JA","year":"2005"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<200::AID-JMV14>3.0.CO;2-O"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.2.177"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/342601"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01115.x"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/315242"},{"issue":"1","key":"e_1_2_10_12_2","first-page":"8","article-title":"Indirect effects of CMV in the solid organ transplant patient","volume":"1","author":"Paya CV","year":"1999","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"e_1_2_10_13_2","first-page":"3","article-title":"Importance of CMV in the transplant population","volume":"1","author":"Rubin RH","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"e_1_2_10_14_2","first-page":"3347","article-title":"Human cytomegalovirus infection and expression in human malignant glioma","volume":"62","author":"Cobbs CS","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000061607.07985.BD"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.468"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199208000-00010"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1994.tb01398.x"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000080263.46164.97"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.61"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199210000-00013"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199304000-00032"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20907.x"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905133401903"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.05.021"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00316.x"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-4-199702150-00003"},{"issue":"5","key":"e_1_2_10_28_2","first-page":"523","article-title":"Cytomegalovirus increases the rate of graft loss after liver transplantation","volume":"3","author":"Hardinger KL","year":"2003","journal-title":"Am J Transplant"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20523"},{"key":"e_1_2_10_30_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0012.1997.tb00847.x","article-title":"Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for liver transplantation CMVIG study group","volume":"11","author":"Falagas ME","year":"1997","journal-title":"Clin Transplant"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00451.x"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06200.x"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-08-0523"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000109692.16004.AF"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(20)30708-X"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11524-8"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/514142"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/375194"},{"key":"e_1_2_10_39_2","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Hodson EM","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/427509"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01190.x"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-12-200512200-00005"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200011270-00012"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200018030-00004"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000150024.01672.CA"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg283"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1086\/382753"},{"issue":"12","key":"e_1_2_10_48_2","article-title":"Extended use of valganciclovir is not associated with development of drug resistant CMV in kidney and pancreas transplant patients","volume":"6","author":"Uknis ME","year":"2006","journal-title":"Am J Transplant"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05535-9"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029500600401"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856010-00012"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2811-2815.2000"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00382.x"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544050-00003"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000164512.99703.AD"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00797.x"},{"key":"e_1_2_10_57_2","first-page":"22","article-title":"Impact of neutropenia on posttransplant management of cytomegalovirus","volume":"22","author":"Boeckh M.","year":"2005","journal-title":"Clinician"},{"issue":"8","key":"e_1_2_10_58_2","first-page":"338","article-title":"Use of valgancyclovir in the prophylaxis, pre\u2010emptive and directed therapy following solid organ transplantation","volume":"4","author":"Bonatti H","year":"2004","journal-title":"Am J Transplant"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.3.452"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000079616.71891.F5"},{"issue":"8","key":"e_1_2_10_61_2","first-page":"354","article-title":"MMF dose modification following GI complications in renal transplantation","volume":"4","author":"Schnitzler MA","year":"2004","journal-title":"Am J Transplant"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2000.020104.x"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1086\/319227"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905253202105"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.1.8025741"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.5.1265"},{"issue":"5","key":"e_1_2_10_67_2","first-page":"504","article-title":"Lower risk of developing CMV disease in high risk patients with 6\u2003months of prophylactic ganciclovir","volume":"3","author":"Doyle A","year":"2003","journal-title":"Am J Transplant"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.11.092"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2004.00066.x"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00571.x"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2006.00618.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2006.00618.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T22:37:23Z","timestamp":1736635043000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2006.00618.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1399-0012.2006.00618.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2006.00618.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}